Skip to main content
Matthew Shtrahman, MD, Neurology, Sylmar, CA

MatthewShtrahmanMD

Neurology Sylmar, CA

Neurophysiology

Physician

Dr. Shtrahman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Shtrahman's full profile

Already have an account?

  • Office

    14445 Olive View Dr
    Sylmar, CA 91342
    Phone+1 818-364-3242
    Fax+1 619-543-3183

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Clinical Neurophysiology, 2014
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2008 - 2011
  • Allegheny Health Network Medical Education Consortium (WPH)
    Allegheny Health Network Medical Education Consortium (WPH)Internship, Transitional Year, 2007 - 2008
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 2007

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - 2025
  • OK State Medical License
    OK State Medical License 2014 - 2025
  • NY State Medical License
    NY State Medical License 2020 - 2024
  • CT State Medical License
    CT State Medical License 2020 - 2023
  • FL State Medical License
    FL State Medical License 2019 - 2023
  • MS State Medical License
    MS State Medical License 2019 - 2023
  • NJ State Medical License
    NJ State Medical License 2021 - 2023
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Clinical Neurophysiology
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Uncertainty and Excitement Surround One Company’s Cell Therapy for Epilepsy
    Uncertainty and Excitement Surround One Company’s Cell Therapy for EpilepsyOctober 6th, 2023